CONMED Corporation (CNMD)

CONMED Corporation is a medical technology company focused on devices and equipment used in surgical procedures. Its product portfolio spans orthopedic surgery solutions, including soft tissue fixation products, resection instruments, fluid management systems, visualization systems, and related single-use products used in minimally invasive sports medicine procedures. The company also markets powered bone surgery systems under the Hall brand for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries.

In general surgery, CONMED supplies clinical insufflation systems, smoke removal devices, endomechanical products, and electrosurgical systems. It also provides endoscopic technologies for gastroenterology procedures, along with products used in dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring. The company sells primarily to hospitals, ambulatory surgery centers, and other healthcare institutions, and also distributes through medical specialty channels. CONMED was incorporated in 1970 and is headquartered in Largo, Florida.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CNMD
$74.22
50.7% Upside
Bargain
$45.50
-7.6% Downside
Fair
Great
0.0%
26.1x
1.4x
1.1x
1.475 B
2.272 B
36.3%
99.0%
3.9
21.9%
238.0%
Valuation • Fair Value

CONMED Corporation (NYSE-CNMD) Fair Value by Valuation Model

Review the available estimates for CONMED Corporation (NYSE-CNMD), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$74.22

Estimated upside of 50.7% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$85.73

Discounted cash flow valuation reference.

Ben Graham Formula Value

$20.93

Classic Ben Graham valuation formula reference.

EPV Fair Value

$39

Earnings power value estimate.

Comps Fair Value

$68.58

Comparable-company valuation reference.

Analyst Price Target

$45.50

Analysts imply downside of 7.6%.

How to read these valuation models

Use the 7 available valuation references for CONMED Corporation (NYSE-CNMD) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for CONMED Corporation (NYSE-CNMD)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.372 B

Current operating scale indicator.

Revenue Forecast

1.366 B

Forward revenue estimate.

EBITDA

227.5 M

Current operating profitability reference.

EBITDA Forecast

280.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review CONMED Corporation (NYSE-CNMD) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for CONMED Corporation (NYSE-CNMD)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.69

No elevated caution signal from this screen.

Altman Z-Score

3.9

Relatively strong balance-sheet zone.

FCF / Net Income

238.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for CONMED Corporation (NYSE-CNMD). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for CONMED Corporation (NYSE-CNMD)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

Payout Ratio

21.9%

Dividend payout reference.

How to read events and dividends

The latest data indicates no current dividend yield for CONMED Corporation (NYSE-CNMD). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

CONMED Corporation (NYSE-CNMD) Stock Forecast & Technical Outlook

Review CONMED Corporation (NYSE-CNMD) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for CONMED Corporation (NYSE-CNMD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for CONMED Corporation (NYSE-CNMD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for CONMED Corporation (NYSE-CNMD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for CONMED Corporation (NYSE-CNMD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for CONMED Corporation (NYSE-CNMD) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for CONMED Corporation (NYSE-CNMD)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, CONMED Corporation (NYSE-CNMD) has a Hold consensus, with 0 buy, 6 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 6
Sell 0
FAQ • Fast Investor Answers

CONMED Corporation (NYSE-CNMD) Stock FAQ

Data-supported answers about CONMED Corporation (NYSE-CNMD), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$74.22
Estimated upside 50.7%
Valuation Rating
Undervalued
Estimated upside of 50.7%
Analyst Target
$45.50
Implied downside 7.6%
Financial Health
Great
Current financial-health read

The current fair value estimate for CONMED Corporation (NYSE-CNMD) is $74.22. This implies an estimated upside of 50.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 50.7% versus the current market price.

The available analyst price target for CONMED Corporation (NYSE-CNMD) is $45.50. The analyst target implies estimated downside of 7.6%.

The current financial health read for CONMED Corporation (NYSE-CNMD) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for CONMED Corporation (NYSE-CNMD).

The current P/E ratio listed for CONMED Corporation (NYSE-CNMD) is 26.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for CONMED Corporation is 1.475 B.

The current enterprise value listed for CONMED Corporation is 2.272 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for CONMED Corporation is NYSE-CNMD, and the stock is listed on NYSE.

CONMED Corporation (NYSE-CNMD) is listed on NYSE.

The current debt-to-total-capital ratio listed for CONMED Corporation is 36.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for CONMED Corporation is 99.0%. Free float helps investors understand how much of the share base is available for public trading.